Cysteinyl leukotrienes and their receptors: (Cellular distribution and function in immune and inflammatory responses

被引:272
作者
Kanaoka, Y
Boyce, AA
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[4] Partner Asthma Ctr, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.173.3.1503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The cysteinyl leukotrienes (cys-LTs) are a family of potent bioactive lipids that act through two structurally divergent G protein-coupled receptors, termed the CysLT(1) and CysLT(2) receptors. The cloning and characterization of these two receptors has not only reconciled findings of previous pharmacologic profiling studies of contractile tissues, but also has uncovered their expression on a wide array of circulating and tissue-dwelling leukocytes. With the development of receptor-selective reagents, as well as mice lacking critical biosynthetic enzymes, transporter proteins, and the CysLT(1) receptor, diverse functions of cys-LTs and their receptors in immune and inflammatory responses have been identified. We review cys-LT biosynthesis; the molecular biology and distribution of the CysLT(1) and CysLT(2) receptors, the functions of cys-LTs and their receptors in the recruitment and activation of effector leukocytes and induction of adaptive immunity; and the development of fibrosis and airway remodeling in animal models of lung injury and allergic inflammation.
引用
收藏
页码:1503 / 1510
页数:8
相关论文
共 86 条
[1]
Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent [J].
Accomazzo, MR ;
Rovati, GE ;
Viganò, T ;
Hernandez, A ;
Bonazzi, A ;
Bolla, M ;
Fumagalli, F ;
Viappiani, S ;
Galbiati, E ;
Ravasi, S ;
Albertoni, C ;
Di Luca, M ;
Caputi, A ;
Zannini, P ;
Chiesa, G ;
Villa, AM ;
Doglia, SM ;
Folco, G ;
Nicosia, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (01) :266-272
[2]
RELEASE OF SMOOTH MUSCLE CONTRACTING SUBSTANCES FROM ISOLATED PERFUSED LUNGS [J].
ALABASTER, VA ;
BAKHLE, YS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (02) :349-360
[3]
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist [J].
Altman, LC ;
Munk, Z ;
Seltzer, J ;
Noonan, N ;
Shingo, S ;
Zhang, J ;
Reiss, TF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (01) :50-56
[4]
INTERCONVERSION OF LEUKOTRIENES CATALYZED BY PURIFIED GAMMA-GLUTAMYL-TRANSFERASE TRANSPEPTIDASE - CONCOMITANT FORMATION OF LEUKOTRIENE D4 AND GAMMA-GLUTAMYL-TRANSFERASE AMINO-ACIDS [J].
ANDERSON, ME ;
ALLISON, RD ;
MEISTER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (04) :1088-1091
[5]
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma [J].
Asano, K ;
Shiomi, T ;
Hasegawa, N ;
Nakamura, H ;
Kudo, H ;
Matsuzaki, T ;
Hakuno, H ;
Fukunaga, K ;
Suzuki, Y ;
Kanazawa, M ;
Yamaguchi, K .
PHARMACOGENETICS, 2002, 12 (07) :565-570
[6]
Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils [J].
Bandeira-Melo, C ;
Hall, JC ;
Penrose, JF ;
Weller, PF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) :975-979
[7]
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion [J].
Bandeira-Melo, C ;
Woods, LJ ;
Phoofolo, M ;
Weller, PF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :841-850
[8]
Chemotaxis and transendothelial migration of CD34+ hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1 [J].
Bautz, F ;
Denzlinger, C ;
Kanz, L ;
Möhle, R .
BLOOD, 2001, 97 (11) :3433-3440
[9]
Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis [J].
Beller, TC ;
Friend, DS ;
Maekawa, A ;
Lam, BK ;
Austen, KF ;
Kanaoka, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :3047-3052
[10]
Eosinophil lipid bodies: Specific, inducible intracellular sites for enhanced eicosanoid formation [J].
Bozza, PT ;
Yu, WG ;
Penrose, JF ;
Morgan, ES ;
Dvorak, AM ;
Weller, PF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :909-920